Imprivata Expands Relationship with Baystate Health; Launches TechSpring Innovation Center Program Series
Imprivata Chief Medical officer Dr. Sean Kelly to Speak at Tap Into TechSpring Networking Event May 12th as part of new Joint Innovation Program and Speaking Series
Lexington, Mass.–May 10, 2016—Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced the Company’s expanded relationship with Baystate Health’s TechSpring Technology Innovation Center, as well as an upcoming event featuring Imprivata’s Chief Medical Officer Dr. Sean Kelly.
Imprivata and Baystate have partnered many times to date, including on a TechSpring project that helped deploy Imprivata’s authentication solution for electronic prescribing of controlled substances (EPCS), Imprivata Confirm ID, as well as the implementation of Imprivata’s secure messaging solution, Imprivata Cortext, across the Pioneer Valley Information Exchange (PVIX). Baystate is also implementing Imprivata OneSign—the single sign-on solution that enables care providers to spend less time with technology and more time with patients.
“We are excited to be working with TechSpring again to continue driving new, innovative solutions for the hospital market,” shared Dr. Kelly. “We value the ability to work directly with a dynamic health system like Baystate in the development of our security platforms, to ultimately build better, stronger products.”
“Partners like Imprivata are key as we continue to define new ways of delivering health care to our patients here in Western Massachusetts,” said Joel Vengco, VP/CIO, Baystate Health and founder of TechSpring. “Better workflow, communication, and security solutions ultimately enable better care, and that’s something we’re very excited to provide to our community.”
If you’re interested in attending Tap Into TechSpring, please RSVP here. Further information about the event is below.
What: Tap Into TechSpring, a town-hall night of innovation and networking
When: Thursday, May 12, 2016 at 5:00 PM
Where: TechSpring, 1350 Main Street, 5th Floor, Springfield, MA 01103
Who: Imprivata Chief Medical Officer Dr. Sean Kelly will address the growing security threat to today’s hospitals, and what they can do to protect themselves and their patients.
Twitter: Follow the conversation with @TechSpringMA and @Imprivata using #TapIntoTechSpring.
About TechSpring, the Baystate Health Technology Innovation Center
TechSpring is a technology Innovation & Adoption Accelerator leveraging the assets of a large integrated health system to overcome barriers for technology innovation and adoption in healthcare in collaboration with leading technology companies as well as technology startups. TechSpring Insights offers focus groups and other feedback mechanisms critical to innovators. TechSpring Adoption Accelerator facilitates in-vivo innovation projects creating proof-points that pave the way to adoption and market success. Visit: www.techspringhealth.org/media
About Baystate Health
Baystate Health is a not-for-profit healthcare organization serving over 750,000 people throughout western New England. Services include an academic medical center, community hospitals, medical practices, homecare and hospice, regional reference lab, and the insurer Health New England. As part of a state-wide $1 billion healthcare innovation initiative in Massachusetts, Baystate Health launched an innovation and adoption accelerator, TechSpring, to match private enterprise with partners to take on some of healthcare’s most difficult challenges. Visit www.baystatehealth.org.
Imprivata® (NYSE: IMPR), the healthcare IT security company, provides healthcare organizations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications, and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate, and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. For more information, please visit www.imprivata.com.